FinscoFinsco

CVS Health (US.CVS)

Capital Allocation Audit · Period: 2010 – 2026

$Open the interactive terminal to run `audit` and explore all dimensions.→

Key Metrics

US.CVS · YoY: 2026 Q1 vs 2025 Q1

MetricValueYoY
FCF Conversion80.0%→
ROE3.8%↑
Cash Conversion144.4%↓
D/E Ratio1.01→
Gross Margin15.6%→
US.CVS (CVS Health) | YoY: 2026 Q1 vs 2025 Q1


Metric            Value  YoY
----------------------------
FCF Conversion    80.0%    →
ROE                3.8%    ↑
Cash Conversion  144.4%    ↓
D/E Ratio          1.01    →
Gross Margin      15.6%    →
Key Metrics
US.CVS (CVS Health) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY
----------------------------
FCF Conversion 80.0% →
ROE 3.8% ↑
Cash Conversion 144.4% ↓
D/E Ratio 1.01 →
Gross Margin 15.6% →

Audit Dimensions

Capital FlowReturnsEarning QualityDebt DisciplineMoat

Unlimited Companies

AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies